engleski

Pharmacogenetic approach in metabolic syndrome therapy

Metabolic syndrome as a group of disorders poses a higher risk of coronary heart disease and type 2 diabetes mellitus. The basic therapeutic objectives are overweight reduction, physical acivity and treatment of risk factors such as hypertension, coagulation tendency and dyslipidaemia.

Pharmacogenetic; Metabolic syndrome

nije evidentirano